Literature DB >> 10218793

Tetrodotoxin-resistant sodium channels of dorsal root ganglion neurons are readily activated in diabetic rats.

M Hirade1, H Yasuda, M Omatsu-Kanbe, R Kikkawa, H Kitasato.   

Abstract

To clarify the mechanism of hyperalgesia in diabetic neuropathy, we investigated the effects of streptozocin-induced hyperglycemia on tetrodotoxin-resistant Na+ channel activity of dorsal root ganglion neurons. Experiments were performed on enzymatically isolated neurons of dorsal root ganglia dissected from streptozocin-induced diabetic and their age-matched control rats. Membrane currents were recorded using the whole-cell patch-clamp technique. Mean current density of tetrodotoxin-resistant Na+ channels was significantly larger in neurons prepared from diabetic rats than in control neurons. Tetrodotoxin-resistant Na+ channels were activated at more negative potentials in diabetic than in control neurons. Curves representing the steady-state inactivation and the peak Na+ conductance as a function of membrane potential shifted to the negative side. The changes in gating property of the Na+ channel were observed six weeks after the injection of streptozocin, and still after eight months, indicating that tetrodotoxin-resistant Na+ channel abnormality starts to develop early and persists during the whole period of diabetes. These results suggest that neurons participating in nociception are highly excitable in diabetic animals. The present results may provide an important clue to the elucidation of hyperalgesia in diabetes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10218793     DOI: 10.1016/s0306-4522(98)00486-2

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  17 in total

Review 1.  Na(+) channel blockers for the treatment of pain: context is everything, almost.

Authors:  Michael S Gold
Journal:  Exp Neurol       Date:  2007-12-08       Impact factor: 5.330

Review 2.  The role of sodium channels in painful diabetic and idiopathic neuropathy.

Authors:  Giuseppe Lauria; Dan Ziegler; Rayaz Malik; Ingemar S J Merkies; Stephen G Waxman; Catharina G Faber
Journal:  Curr Diab Rep       Date:  2014-10       Impact factor: 4.810

Review 3.  [Painful hyperexcitability syndrome with oxaliplatin containing chemotherapy. Clinical features, pathophysiology and therapeutic options].

Authors:  T Kowalski; C Maier; A Reinacher-Schick; U Schlegel
Journal:  Schmerz       Date:  2008-02       Impact factor: 1.107

4.  Dynamic changes of neuroskeletal proteins in DRGs underlie impaired axonal maturation and progressive axonal degeneration in type 1 diabetes.

Authors:  Hideki Kamiya; Weixian Zhang; Anders A F Sima
Journal:  Exp Diabetes Res       Date:  2009-10-12

5.  Antinociceptive activities of lidocaine and the nav1.8 blocker a803467 in diabetic rats.

Authors:  Tufan Mert; Yasemin Gunes
Journal:  J Am Assoc Lab Anim Sci       Date:  2012       Impact factor: 1.232

6.  Early painful diabetic neuropathy is associated with differential changes in tetrodotoxin-sensitive and -resistant sodium channels in dorsal root ganglion neurons in the rat.

Authors:  Shuangsong Hong; Thomas J Morrow; Pamela E Paulson; Lori L Isom; John W Wiley
Journal:  J Biol Chem       Date:  2004-05-03       Impact factor: 5.157

Review 7.  Acetyl-L-carnitine in diabetic polyneuropathy: experimental and clinical data.

Authors:  Anders A F Sima
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

8.  Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy.

Authors:  Angelika Bierhaus; Thomas Fleming; Stoyan Stoyanov; Andreas Leffler; Alexandru Babes; Cristian Neacsu; Susanne K Sauer; Mirjam Eberhardt; Martina Schnölzer; Felix Lasitschka; Felix Lasischka; Winfried L Neuhuber; Tatjana I Kichko; Ilze Konrade; Ralf Elvert; Walter Mier; Valdis Pirags; Ivan K Lukic; Michael Morcos; Thomas Dehmer; Naila Rabbani; Paul J Thornalley; Diane Edelstein; Carla Nau; Josephine Forbes; Per M Humpert; Markus Schwaninger; Dan Ziegler; David M Stern; Mark E Cooper; Uwe Haberkorn; Michael Brownlee; Peter W Reeh; Peter P Nawroth
Journal:  Nat Med       Date:  2012-06       Impact factor: 53.440

9.  The beneficial effects of C-Peptide on diabetic polyneuropathy.

Authors:  Hideki Kamiya; Weixian Zhang; Anders A F Sima
Journal:  Rev Diabet Stud       Date:  2009-11-10

10.  n5-STZ Diabetic Model Develops Alterations in Sciatic Nerve and Dorsal Root Ganglia Neurons of Wistar Rats.

Authors:  Francisco Walber Ferreira-da-Silva; Kerly Shamyra da Silva-Alves; Matheus Lemos-Dos-Santos; Keciany Alves de Oliveira; Humberto Cavalcante Joca; Otoni Cardoso do Vale; Andrelina Noronha Coelho-de-Souza; José Henrique Leal-Cardoso
Journal:  ISRN Endocrinol       Date:  2013-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.